Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Icerguastat by InFlectis BioScience for Charcot-Marie-Tooth Disease Type I B: Likelihood of Approval
Icerguastat is under clinical development by InFlectis BioScience and currently in Phase I for Charcot-Marie-Tooth Disease Type I B. According...
Data Insights
Icerguastat by InFlectis BioScience for Charcot-Marie-Tooth Disease Type I A: Likelihood of Approval
Icerguastat is under clinical development by InFlectis BioScience and currently in Phase I for Charcot-Marie-Tooth Disease Type I A. According...